Insulin resistance, affective disorders, and Alzheimer's disease: review and hypothesis.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  The journals of gerontology. Series A, Biological sciences and medical sciences

• Publication date

  2004-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/GERONA/59.2.M178PMID 14999034
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Depression as a risk factor for Alzheimer disease: the MIRAGE Study.

  2003cited by this paper
• Diabetes, Alzheimer's disease and apolipoprotein genotype.

  2003cited by this paper
• Abnormalities in glucose regulation associated with mental illness and treatment.

  2002cited by this paper
• Alzheimer Disease as a Vascular Disorder: Nosological Evidence

  2002cited by this paper
• Metformin for weight loss in pediatric patients taking psychotropic drugs.

  2002cited by this paper
• Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: a preliminary report.

  2002cited by this paper
• Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression.

  2002cited by this paper
• Psychotropic drugs and adverse events in the treatment of bipolar disorders revisited.

  2002cited by this paper
• Correlates of overweight and obesity in 644 patients with bipolar disorder.

  2002cited by this paper
• Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients.

  2001cited by this paper
• Brain metabolic changes associated with symptom factor improvement in major depressive disorder.

  2001cited by this paper
• Depression, anxiety, and the cardiovascular system: the cardiologist's perspective.

  2001cited by this paper
• Affective disorders and Alzheimer disease: a missing-link hypothesis.

  2001cited by this paper
• Effect of donepezil on brain acetylcholinesterase activity in patients with AD measured by PET

  2001cited by this paper
• Declining brain activity in cognitively normal apolipoprotein E ɛ4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease

  2001cited by this paper
• The brain-lipid-heart connection.

  2001cited by this paper
• A neuropathological study of vascular factors in late-life depression

  2001cited by this paper
• Depression, antidepressants, and the shrinking hippocampus

  2001cited by this paper
• LDL receptor‐related protein (LRP) in Alzheimer's disease: Towards a unified theory of pathogenesis

  2000cited by this paper
• The Renin Angiotensin System and Alzheimer's Disease

  2000cited by this paper
• FDG PET imaging in patients with pathologically verified dementia.

  2000cited by this paper
• PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review

  2000cited by this paper
• Insulin resistance in patients with depression and its changes during the clinical course of depression: minimal model analysis.

  2000cited by this paper
• Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease.

  2000cited by this paper
• Tyrosine hydroxylase gene microsatellite polymorphism associated with insulin resistance in depressive disorder.

  2000cited by this paper
• Perfusion abnormalities in prodromal AD.

  2000cited by this paper
• Elevated levels of insulin, leptin, and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses.

  2000cited by this paper
• Metabolic factors that affect beta-cell function and survival.

  2000cited by this paper
• Insulin Effects on Glucose Metabolism, Memory, and Plasma Amyloid Precursor Protein in Alzheimer's Disease Differ According to Apolipoprotein‐E Genotype

  2000cited by this paper
• Six‐month test–retest reliability of MRI‐defined PET measures of regional cerebral glucose metabolic rate in selected subcortical structures

  2000cited by this paper
• Insulin Metabolism in Alzheimer’s Disease Differs According to Apolipoprotein E Genotype and Gender

  1999influential reference
• PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders.

  1999cited by this paper
• Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients.

  1999cited by this paper
• New gene targets related to schizophrenia and other psychiatric disorders: enzymes, binding proteins and transport proteins involved in phospholipid and fatty acid metabolism.

  1999cited by this paper
• The Insulin Receptor Tyrosine Kinase Substrate p58/53 and the Insulin Receptor Are Components of CNS Synapses

  1999cited by this paper
• The temporal relationship between depressive symptoms and dementia: a community-based prospective study.

  1999cited by this paper
• Glucose intolerance, cognitive impairment and Alzheimer's disease.

  1998cited by this paper
• Are psychoactive-drug-induced changes in plasma lipid and lipoprotein levels of significance for clinical remission in psychiatric disorders?

  1998cited by this paper
• Preclinical prediction of Alzheimer's disease using SPECT

  1998cited by this paper
• Neurochemical imaging of Alzheimer's disease and other degenerative dementias.

  1998cited by this paper
• The role of N-methyl-D-aspartate (NMDA) receptor-mediated neurotransmission in the pathophysiology and therapeutics of psychiatric syndromes.

  1998cited by this paper
• Neuroimaging abnormalities in the subgenual prefrontal cortex: implications for the pathophysiology of familial mood disorders

  1998cited by this paper
• Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease

  1998cited by this paper
• Banting lecture 1988

  1997cited by this paper
• Estrogen effects on cognition in menopausal women

  1997cited by this paper
• Cingulate function in depression: a potential predictor of treatment response

  1997cited by this paper
• 311C90: Increasing the options for therapy with effective acute antimigraine 5HT1B/1D receptor agonists

  1997cited by this paper
• Fluoxetine improves insulin sensitivity in obese patients with non-insulin-dependent diabetes mellitus independently of weight loss

  1997cited by this paper
• Subgenual prefrontal cortex abnormalities in mood disorders

  1997cited by this paper
• Levels and Risks of Depression and Anxiety Symptomatology Among Diabetic Adults

  1997cited by this paper
• Cognitive Impairment in Affective Disorders: Relation to Illness Characteristics

  1996cited by this paper
• Clinical and Magnetic Resonance Imaging Correlates of Hypothalamic–Pituitary–Adrenal Axis Function in Depression and Alzheimer's Disease

  1996cited by this paper
• Diabetes mellitus in schizophrenic patients.

  1996cited by this paper
• Brain Glucose Metabolism Is Controlled by Amplification and Desensitization of the Neuronal Insulin Receptor a

  1996cited by this paper
• Epidemiological evidence for the association of hyperglycaemia and atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus.

  1996cited by this paper
• Memory improvement following induced hyperinsulinemia in Alzheimer's disease.

  1996cited by this paper
• Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease.

  1995cited by this paper
• Corticotropin Releasing Hormone in the Pathophysiology of Melancholic and Atypical Depression and in the Mechanism of Action of Antidepressant Drugs

  1995cited by this paper
• Hypothesis: low serum cholesterol, suicide, and interleukin-2.

  1995cited by this paper
• History of Depression as a Risk Factor for Alzheimer's Disease

  1995cited by this paper
• Paralimbic hypoperfusion in unipolar depression.

  1994cited by this paper
• Brain Imaging Studies of Antidepressant Treatments

  1994cited by this paper
• Enhancing central and peripheral insulin activity as a strategy for the treatment of endogenous depression--an adjuvant role for chromium picolinate?

  1994cited by this paper
• Steroid potentiation and inhibition of N-methyl-D-aspartate receptor-mediated intracellular Ca++ responses: structure-activity studies.

  1994cited by this paper
• Comparison of cholinergic drug effects on regional brain glucose consumption in rats and humans by means of autoradiography and position emission tomography.

  1994cited by this paper
• Effect of hyperinsulinaemia on the function of the pituitary‐adrenal axis in healthy man

  1994cited by this paper
• Psychosocial factors and prognosis in established coronary artery disease. The need for research on interventions.

  1993cited by this paper
• Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

  1993cited by this paper
• Growth and sexual maturation in children with insulin-dependent diabetes mellitus.

  1993cited by this paper
• Tetanus‐Diphtheria Immunizations in a Nursing Home Population

  1992cited by this paper
• Coexistence of Alzheimer's Disease and Diabetes Mellitus

  1992cited by this paper
• Raised glucose levels enhance scopolamine-induced acetylcholine overflow from the hippocampus: an in vivo microdialysis study in the rat.

  1992cited by this paper
• Glucose, Insulin, and Insulin‐Like Growth Factor I Regulate the Glycogen Content of Astroglia‐Rich Primary Cultures

  1992cited by this paper
• Fluoxetine increases insulin action in obese nondiabetic and in obese non-insulin-dependent diabetic individuals.

  1992cited by this paper
• Effects of cholinergic agonists on regional brain energy metabolism in the scopolamine-treated rat.

  1992cited by this paper
• Pet Studies of Cerebral Function in Major Depression and Obsessive-CompulsiveDisorder: the Emerging Prefrontal Cortex Consensus

  1991cited by this paper
• Higher Glycemic Thresholds for Symptoms During β-Adrenergic Blockade in IDDM

  1991cited by this paper
• A review of insulin/insulin-like peptide in the central nervous system.

  1991cited by this paper
• Improvement of Insulin-Induced Glucose Disposal in Obese Patients With NIDDM After 1-Wk Treatment With d-Fenfluramine

  1991cited by this paper
• Higher glycemic thresholds for symptoms during beta-adrenergic blockade in IDDM.

  1991cited by this paper
• Cognitive impairment and cerebral structure by MRI in bipolar disorder.

  1990cited by this paper
• Left prefrontal glucose hypometabolism in the depressed state: a confirmation.

  1990cited by this paper
• Regional Cerebral Blood Flow in Patients with Affective Disorders

  1990cited by this paper
• Regulation of rat brain/HepG2 glucose transporter gene expression by insulin and insulin-like growth factor-I in primary cultures of neuronal and glial cells.

  1989cited by this paper
• Clinical significance of psychoneuroendocrinology in psychiatry: focus on the thyroid and adrenal.

  1989cited by this paper
• Fenfluramine Increases Insulin Action in Patients With NIDDM

  1989cited by this paper
• Brain changes in geriatric depression

  1988cited by this paper
• Abnormal cortisol response in Alzheimer's disease linked to hippocampal atrophy.

  1988cited by this paper
• Banting lecture 1988. Role of insulin resistance in human disease.

  1988cited by this paper
• Insulin resistance after oral glucose tolerance testing in patients with major depression.

  1988cited by this paper
• Role of Insulin Resistance in Human Disease

  1988cited by this paper
• DIABETES AND SCHIZOPHRENIA—A PRELIMINARY STUDY

  1986cited by this paper
• Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness.

  1986cited by this paper
• Conditioning and Sensitisation in the Longitudinal Course of Affective Illness

  1986cited by this paper
• Autoradiographic localization of insulin receptors in rat brain: prominence in olfactory and limbic areas.

  1986cited by this paper
• Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18.

  1985cited by this paper
• Differential response of plasma glucose, amino acids and nonesterified fatty acids to insulin in depressed patients.

  1984cited by this paper
• Insulin inhibits pyramidal neurons in hippocampal slices.

  1984cited by this paper
• Psychiatric implications of basic and clinical studies with corticotropin-releasing factor.

  1984cited by this paper
• Insulin binds to specific receptors and stimulates 2-deoxy-D-glucose uptake in cultured glial cells from rat brain.

  1984cited by this paper

• The association of the triglyceride-glucose index and its changes with 5-year all-cause mortality in patients with depression

  2025cites this paper
• The association between lipid accumulation products and depression in U.S. adults: A cross-sectional study from NHANES 2005-2018

  2024cites this paper
• Sex-Specific Elevated Fasting Glucose in Patients with Major Depressive Disorder.

  2024cites this paper
• Nose-to-brain delivery of insulin nanoparticles for diabetes management: A review

  2023cites this paper
• Hesperetin, a Promising Treatment Option for Diabetes and Related Complications: A Literature Review.

  2022cites this paper
• Sleep Deprivation and Circadian Disruption Stress, Allostasis, and Allostatic Load.

  2022cites this paper
• The effect of insulin receptor deletion in neuropeptide Y neurons on hippocampal dependent cognitive function in aging mice.

  2022cites this paper
• Nose-to-Brain Delivery of Therapeutic Peptides as Nasal Aerosols

  2022cites this paper
• Hippocampal-specific insulin resistance elicits behavioral despair and hippocampal dendritic atrophy

  2021cites this paper
• Multidimensional predictors of antidepressant responses: Integrating mitochondrial, genetic, metabolic and environmental measures with clinical outcomes

  2021cites this paper
• Multidimensional predictors of antidepressant responses: Integrating mitochondrial, genetic, metabolic and environmental factors with clinical outcomes

  2021cites this paper
• Incident Major Depressive Disorder Predicted by Three Measures of Insulin Resistance: A Dutch Cohort Study.

  2021cites this paper
• The interactions between Alzheimer´s disease and major depression: Role of Ca2+ channel blockers and Ca2+/cAMP signalling.

  2020cites this paper
• Epigenetic impact of the social and physical environment on brain and body.

  2019cites this paper
• Childhood trauma and insulin resistance in patients suffering from depressive disorders

  2019cites this paper
• Diet quality and eating patterns in euthymic bipolar patients.

  2019cites this paper
• Inflammation, insulin resistance and neuroprogression in depression

  2019influential citation
• Body Fluid pH Balance in Metabolic Health and Possible Benefits of Dietary Alkaline Foods

  2019cites this paper
• Factors related to metabolic parameters in medicated patients with major depressive disorder--a naturalistic study.

  2018cites this paper
• A review of brain insulin signaling in mood disorders: From biomarker to clinical target

  2018cites this paper
• Insulin Resistance in Alzheimer ’ s Disease 1 MedDocs eBooks

  2018cites this paper
• Emotional and Psychological Needs of People with Diabetes

  2018cites this paper
• Indices of insulin resistance and glucotoxicity are not associated with bipolar disorder or major depressive disorder, but are differently associated with inflammatory, oxidative and nitrosative biomarkers.

  2017cites this paper
• Redefining neuroendocrinology: Epigenetics of brain-body communication over the life course.

  2017cites this paper
• The relationship between atypical depression and insülin resistance in patients with polycystic ovary syndrome and major depression.

  2017influential citation
• Novel calcium-related targets of insulin in hippocampal neurons.

  2017cites this paper
• Insulin deficiency: A possible link between obesity and cognitive function

  2017influential citation
• INSULIN ACTIONS ON HIPPOCAMPAL NEURONS

  2017cites this paper
• Psychosocial Issues and Type 2 Diabetes

  2016cites this paper
• Insulin resistance—a missing link no more

  2016cites this paper
• Repurposing of Anti-Diabetic Agents for the Treatment of Cognitive Impairment and Mood Disorders.

  2016cites this paper
• The expression of insulin-like growth factor-1 in senior patients with diabetes and dementia

  2016cites this paper
• Treatment with Rhodiola crenulata root extract ameliorates insulin resistance in fructose-fed rats by modulating sarcolemmal and intracellular fatty acid translocase/CD36 redistribution in skeletal muscle

  2016cites this paper
• Nutrition in the Etiology and Management of Type 2 Diabetes

  2016cites this paper
• Glucose Metabolism, Insulin, and Aging

  2016cites this paper
• Jiangzhi Capsule improves fructose-induced insulin resistance in rats: Association with repair of the impaired sarcolemmal glucose transporter-4 recycling.

  2016cites this paper
• Roles of interstitial fluid pH in diabetes mellitus: Glycolysis and mitochondrial function.

  2015cites this paper
• A high-sugar high-fat diet induced metabolic syndrome shows some symptoms of Alzheimer's disease in rats

  2015cites this paper
• Association between insulin resistance and cognition in patients with depressive disorders: exploratory analyses into age-specific effects.

  2015influential citation
• Role of insulin resistance in Alzheimer’s disease

  2015cites this paper
• Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer’s Disease Biology: Characterization of Putative Cognates for Therapeutic Applications

  2015cites this paper
• Major depressive disorder and type II diabetes mellitus: mechanisms underlying risk for Alzheimer's disease.

  2015cites this paper
• Sleep Deprivation and Circadian Disruption: Stress, Allostasis, and Allostatic Load.

  2015cites this paper
• Severe Psychiatric Disorders in Mid-Life and Risk of Dementia in Late-Life (Age 65-84 Years): A Population Based Case-Control Study

  2014cites this paper
• Importance of pH Homeostasis in Metabolic Health and Diseases: Crucial Role of Membrane Proton Transport

  2014cites this paper
• The relationship between fasting serum glucose and cerebral glucose metabolism in late-life depression and normal aging.

  2014cites this paper
• Nongenetic Risk Factors for Alzheimer’s Disease

  2014cites this paper
• INTERNATIONAL JOURNAL OF PHARMACOLOGY AND THERAPEUTICS

  2014cites this paper
• Effects of estradiol and genistein on the insulin signaling pathway in the cerebral cortex of aged female rats.

  2014influential citation
• Mitochondrial Dysfunction and Reactive Oxygen Species in Neurodegeneration

  2013cites this paper
• Cumulative estrogen exposure, number of menstrual cycles, and Alzheimer's risk in a cohort of British women.

  2013cites this paper
• Cognitive deficits in geriatric depression: clinical correlates and implications for current and future treatment.

  2013cites this paper
• Homocysteine, depression and cognitive function in older adults.

  2013cites this paper
• Salidroside attenuates beta amyloid-induced cognitive deficits via modulating oxidative stress and inflammatory mediators in rat hippocampus.

  2013cites this paper
• Thyroid hormone’s role in regulating brain glucose metabolism and potentially modulating hippocampal cognitive processes

  2012cites this paper
• Use of insulin sensitizers for the treatment of major depressive disorder: a pilot study of pioglitazone for major depression accompanied by abdominal obesity.

  2012cites this paper
• Insulin in Central Nervous System: More than Just a Peripheral Hormone

  2012cites this paper
• The Role of Peroxisome Proliferator-Activated Receptor-γ PPARγ) in Alzheimer’s Disease

  2012cites this paper
• Rhodiola crenulata root ameliorates derangements of glucose and lipid metabolism in a rat model of the metabolic syndrome and type 2 diabetes.

  2012cites this paper
• Metabolic syndrome and cognitive decline among the oldest old in Okinawa: in search of a mechanism. The KOCOA Project.

  2012cites this paper
• Is BDNF biological link between depression and type 2 diabetes mellitus?

  2012cites this paper
• Inflammatory risk factors and pathologies associated with Alzheimer's disease.

  2011cites this paper
• Diabetes as a risk factor for Alzheimer's disease: insulin signalling impairment in the brain as an alternative model of Alzheimer's disease.

  2011cites this paper
• TRANSPLANTE OVARIANO AUTÓLOGO EM DIFERENTES SÍTIOS ANATÔMICOS DE RATAS OVARIECTOMIZADAS

  2011cites this paper
• An investigation into the antidepressant–like profile of pioglitazone in a genetic rat model of depression

  2011cites this paper
• Increasing Depressive Symptoms in Children of Alzheimer Parents

  2011cites this paper
• Insulin resistance and hippocampal volume in women at risk for Alzheimer's disease.

  2011cites this paper
• Gender-specific lipid profiles in patients with bipolar disorder.

  2011cites this paper
• Functional analysis of the glucose transporters-1a, [corrected] -6, and -13.1 expressed by zebrafish epithelial cells.

  2011cites this paper
• Brain volume abnormalities and neurocognitive deficits in diabetes mellitus: Points of pathophysiological commonality with mood disorders?

  2010cites this paper
• Depression gets old fast: do stress and depression accelerate cell aging?

  2010cites this paper
• Acute effects of 17β-estradiol and genistein on insulin sensitivity and spatial memory in aged ovariectomized female rats

  2010cites this paper
• [Insulin resistance as a mechanism of adaptation during human evolution].

  2010cites this paper
• Are Paradoxical Cell Cycle Activities in Neurons and Glia Related to the Metabolic Theory of Alzheimer's Disease?

  2010cites this paper
• Rosiglitazone Add-On in Treatment of Depressed Patients with Insulin Resistance: a Pilot Study

  2010cites this paper
• Differences in the body composition and biochemistry in women grouped as normal-weight, overweight and obese according to body mass index and their relation with cardiometabolic risk

  2010cites this paper
• La resistencia a la insulina como mecanismo de adaptación durante la evolución humana

  2010cites this paper
• [Vascular risk factors and Alzheimer's disease].

  2009cites this paper
• What is the association between depression and Alzheimer’s disease?

  2009cites this paper
• PCOS, Depression, and Alzheimer’s Disease

  2009cites this paper
• Diabetes and Depression

  2009cites this paper
• An Integrative View of the Role of Oxidative Stress, Mitochondria and Insulin in Alzheimer's Disease

  2009cites this paper
• Alterations in body weight and biochemistry in patient treated with different psychotropic drugs in a clinic in Istanbul

  2009cites this paper
• Significance of soluble CD40 ligand, adiponectin and reactive oxygen metabolites in aging.

  2009cites this paper
• Chronic estradiol treatment improves brain homeostasis during aging in female rats.

  2008cites this paper
• Children of Persons With Alzheimer Disease: What Does the Future Hold?

  2008cites this paper
• The role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in Alzheimer's disease: therapeutic implications.

  2008cites this paper
• Role of Insulin Metabolism Disturbances in the Development of Alzheimer Disease: Mini Review

  2008cites this paper
• HOT FLASHES, BLOOD GLUCOSE AND DIABETIC POSTMENOPAUSAL WOMEN

  2008cites this paper
• Apolipoprotein E epsilon4 allele genotype and the effect of depressive symptoms on the risk of dementia in men: the Honolulu-Asia Aging Study.

  2008cites this paper
• Diabetes and aging: epidemiologic overview.

  2008cites this paper
• Evolutionary origins of insulin resistance: a behavioral switch hypothesis

  2007cites this paper
• New access to Alzheimer’s and other neurodegenerative diseases

  2007cites this paper
• Should Depressive Syndromes Be Reclassified as "Metabolic Syndrome Type II"?

  2007cites this paper
• Is there any relation between insulin resistance and cognitive function in the elderly?

  2007cites this paper
• Sirtuin functions in health and disease.

  2007cites this paper
• Positive Effects of 17β-Estradiol on Insulin Sensitivity in Aged Ovariectomized Female Rats

  2006cites this paper
• Postpartum mood disorders may be related to a decreased insulin level after delivery.

  2006cites this paper
• Managing psychiatric disorders with antidiabetic agents: translational research and treatment opportunities

  2006cites this paper
• Sleep deprivation as a neurobiologic and physiologic stressor: Allostasis and allostatic load.

  2006cites this paper